SCYNEXIS Change in Assets/Liabilities 2013-2025 | SCYX

SCYNEXIS change in assets/liabilities from 2013 to 2025. Change in assets/liabilities can be defined as represents any other changes in assets/liabilities

SCYNEXIS Change in Assets/Liabilities 2013-2025 | SCYX

SCYNEXIS change in assets/liabilities from 2013 to 2025. Change in assets/liabilities can be defined as represents any other changes in assets/liabilities
Related Stocks
Company NameMarket
Cap
Chugai Pharmaceutical (CHGCY)$70B
Zoetis (ZTS)$68.3B
Takeda Pharmaceutical (TAK)$47.7B
Daiichi Sankyo, - (DSNKY)$47.6B
BeOne Medicines - (ONC)$35.2B
Sandoz Group AG (SDZNY)$26.1B
Summit Therapeutics (SMMT)$19.8B
Merck (MKKGY)$17.1B
Shionogi (SGIOY)$15.2B
United Therapeutics (UTHR)$14.1B
Neurocrine Biosciences (NBIX)$13.2B
Orion OYJ (ORINY)$10.8B
IPSEN (IPSEY)$10.6B
Eisai (ESAIY)$9.2B
Madrigal Pharmaceuticals (MDGL)$8.2B
Corcept Therapeutics (CORT)$7.6B
Grifols, S.A (GRFS)$7.4B
Ionis Pharmaceuticals (IONS)$7B
Stevanato Group S.p.A (STVN)$6.9B
Hikma Pharmaceuticals Plc (HKMPF)$5.3B
Ono Pharmaceutical (OPHLF)$5.1B
Soleno Therapeutics (SLNO)$3.8B
AMNEAL PHARMACEUTICALS, INC (AMRX)$3B
Crinetics Pharmaceuticals (CRNX)$2.9B
NewAmsterdam Pharma (NAMS)$2.8B
Hypermarcas (HYPMY)$2.7B
Catalyst Pharmaceuticals (CPRX)$2.5B
Centessa Pharmaceuticals (CNTA)$2.4B
Ocular Therapeutix (OCUL)$2.2B
Endo (NDOI)$1.8B